Showing 4971-4980 of 5646 results for "".
- Alcon Provides Update on COVID-19https://modernod.com/news/alcon-provides-update-on-covid-19/2477538/Alcon announced a series of updates stemming from the impact of COVID-19. Alcon has initiated business continuity plans designed to keep its associates and customers safe while continuing to deliver critical eye care needs for the global healthcare community. These plans include directing
- AAO: Malaria Drugs For COVID-19 Will Not Blind Youhttps://modernod.com/news/aao-malaria-drugs-for-covid-19-will-not-blind-you/2477533/The American Academy of Ophthalmology has shared its latest information about protecting vision during the COVID-19 pandemic. Below are six topics getting a lot of attention right now, and AAO’s recommendations: Avoid touching your eyes By now you
- Inovio Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Todayhttps://modernod.com/news/inovio-initiates-phase-1-clinical-trial-of-its-covid-19-vaccine-and-plans-first-dose-today/2477532/Inovio Pharmaceuticals announced that the FDA has accepted the company’s investigational new drug (IND) application for INO-4800, its DNA vaccine candidate designed to prevent COVID-19 infection, paving the way for phase 1 clinical testing of INO-4800 in healthy volunteers beginning this we
- OD-OD Introduces a New Learning App for Retinal Laser Treatmenthttps://modernod.com/news/od-od-introduces-a-new-learning-app-for-retinal-laser-treatment/2479529/To address growing demand for interactive learning technology, OD-OS has developed a tool for implementing a better approach to retinal laser treatment: The Navigate App. Navigate is a free, interactive tool designed to support residents and team education—both onsite and online. The platf
- ProtoKinetix AAGP Exhibits Efficacy and Safety in Model of Dry Eye Diseasehttps://modernod.com/news/protokinetix-aagp-exhibits-efficacy-and-safety-in-model-of-dry-eye-disease/2479530/ProtoKinetix, which recently announced filing for patent protection for new applications of its AAGP (PKX-001) molecule, announced preliminary results in efficacy and safety for use in treating dry eye disease (DED). PKX-001 demonstrated a protective effect in the murine model of dry eye d
- BlephEx Announces Appeal Victory In Patent Litigation With Myco Industrieshttps://modernod.com/news/blephex-announces-appeal-victory-in-patent-litigation-with-myco-industries/2479532/BlephEx, creator of the BlephEx device and eyelid cleaning procedure, announced a victory before the Court of Appeals for the Federal Circuit in its ongoing patent litigation with Myco Industries
- Luxottica to Donate Hundreds of Thousands of Medical Masks, Outlines COVID-19 Safety and Relief Effortshttps://modernod.com/news/luxottica-to-donate-hundreds-of-thousands-of-medical-masks-outlines-covid-19-safety-and-relief-efforts/2477526/Responding to the COVID-19 pandemic, Luxottica Group has taken a number of steps, both in North America and Italy, to protect customers, employees, partners and medical workers, according to a VisionMonday
- CRST: Hydroxychloroquine for the Treatment and Prevention of COVID-19https://modernod.com/news/hydroxychloroquine-for-the-treatment-and-prevention-of-covid-19/2477524/A new article published online in Cataract & Refractive Surgery Today (CRST) provides an in-depth examination of the use of hydroxychloroquine for both prophylaxis a
- Provider Initiative to Help Ease Financial and Administrative Stress During Coronavirus Pandemichttps://modernod.com/news/provider-initiative-to-help-ease-financial-and-administrative-stress-during-coronavirus-pandemic/2477522/Humana announced a series of actions designed to help provide financial and administrative relief for the health care provider community facing the COVID-19 pandemic. First, Humana is implementing simplified and expedited claims processing in order to get reimbursement payments to provider
- 2020 World Ophthalmology Congress Cancelled; Virtual Program Plannedhttps://modernod.com/news/2020-world-ophthalmology-congress-cancelled-virtual-program-planned/2479534/Due to the COVID-19 pandemic, The International Council of Ophthalmology (ICO) has decided to cancel the World Ophthalmology Congress (WOC2020), scheduled to take place June 26-29, in Cape Town, Africa. In a message to its members, ICO leadership stated that it remains devoted to bringing